← Back to Patent Explorer
US4465691A Expired / Lapsed US ⏱️ 0.0 years remaining

(3,4';4,5)-Pyrido (3,2-g)-furo coumarins or (3,4-h) pyrido psoralens process of preparation, applications in cosmetology and in therapeutics, and cosmetological and pharmaceutical compositions with them

Assignee: Institut National de la Santé et de la Recherche Médicale
•
Filing: 1983-02-24
•
Granted: 1984-08-14
•
Expires: 2003-02-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Pyrido (3,4', 4,5) furo (3,2-g) coumarins or pyrido (3,4-h) psoralens having formula I ##STR1## wherein R is a hydrogen radical or a lower alkyl group having from 1 to 4 carbon atoms and R" is a methyl group or a methoxy group. These compounds are photobiologically active and are useful or medicinals and pharmaceutical compositions in association with ultraviolet radiation for treating skin diseases and as cosmetic compositions for skin pigmentation.

Inventors

  • 👤 Emile Bisagni
  • 👤 Jacqueline Morin
  • 👤 Dietrich Averbeck
  • 👤 Dubertret Louis

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:04
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/60; C07D213/72; C07D213/73; A; A61; A61P; A61P17/00; A61P29/00; A61P37/00; A61P37/08; C07D213/62; C07D213/63; C07D213/68; C07D405/00; C07D405/02; C07D405/12; C07D491/00; C07D491/02; C07D491/04; C07D491/12; C07D491/14

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 53 words
Pyrido (3,4-h) psoralens or pyrido (3,4':4,5)furo (3,2-g) courmarins having the formula I ##STR15## wherein R is selected from the group consisting of a hydrogen atom and a lower alkyl group having from 1 to 4 carbon atoms and R' is selected from the group consisting of a methyl group and a methoxy group.
Claim 2
Dependent Claim 53 words
Pyrido (3,4-h) psoralens or pyrido (3,4':4,5)furo (3,2-g) courmarins having the formula I ##STR15## wherein R is selected from the group consisting of a hydrogen atom and a lower alkyl group having from 1 to 4 carbon atoms and R' is selected from the group consisting of a methyl group and a methoxy group.
Claim 3
Dependent Claim 26 words
Pyrido (3,4-h)psoralens or pyrido (3',4':4,5)furo (3,2-g) coumarins of claim 1, wherein R is selected from the group consisting of a methyl group and a hydrogen atom.
Claim 4
Dependent Claim 17 words
Pyrido (3,4-h) psoralens or pyrido (3',4':4,5)furo (3,2-g) coumarins of claim 1, wherein R' is a methyl group.
Claim 5
Dependent Claim 16 words
Pyrido (3,4-h)psoralens or pyrido (3',4':4,5)furo (3,2-g) coumarins of claim 2, wherein R' is a methyl group.
Claim 6
Dependent Claim 22 words
Pyrido (3,4-h) psoralens or pyrido (3',4':4,5)furo(3,2-g) coumarins of claim 1, wherein R is a hydrogen atom and R' is a methyl group.
Claim 7
Dependent Claim 19 words
Pyrido (3,4-h) psoralens or pyrido (3',4':4,5)furo (3,2-g) coumarins of claim 1, wherein R and R' are both methyl groups.
Claim 8
Dependent Claim 83 words
A pharmaceutical composition useful for treating inflammatory dermatoses or for stimulating the pigmentation of the skin, comprising an amount of pyrido (3,4-h) psoralens or pyrido (3',4';4,5) furo (3,2-g) coumarins having the formula ##STR16## wherein R is selected from the group consisting of a hydrogen atom and a lower alkyl group having from 1 to 4 carbon atoms and R' is selected from the group constisting of a methyl group and a methoxy group; and a pharmaceutically acceptable vehicle for local or oral administration.
Claim 9
Dependent Claim 83 words
A pharmaceutical composition useful for treating inflammatory dermatoses or for stimulating the pigmentation of the skin, comprising an amount of pyrido (3,4-h) psoralens or pyrido (3',4';4,5) furo (3,2-g) coumarins having the formula ##STR16## wherein R is selected from the group consisting of a hydrogen atom and a lower alkyl group having from 1 to 4 carbon atoms and R' is selected from the group constisting of a methyl group and a methoxy group; and a pharmaceutically acceptable vehicle for local or oral administration.
Claim 10
Dependent Claim 20 words
The pharmaceutical composition of claim 7, in a form selected from the group consisting of an ointment and a solution.
Claim 11
Dependent Claim 29 words
The pharmaceutical composition of claim 7, wherein said active ingredient is present in a therapeutically effective amount from about 0.1% to about 2% by weight of the pharmaceutical composition.
Claim 12
Dependent Claim 27 words
The pharmaceutical composition of claim 9, wherein said active ingredient is present in an amount from about 0.5% to about 2% by weight of the pharmaceutical composition.
Claim 13
Dependent Claim 42 words
A method of treating inflammatory dermatoses comprising administering to a patient afflicted with said condition an anti-antiflammatory dermatoses effective amount of the compound of claim 1, or a combination thereof, in combination with irradiation with light in the near ultraviolet range (UVA).
Claim 14
Dependent Claim 11 words
The method of claim 11, wherein the inflammatory dermatosis is psoriasis.

References Cited (Backward Citations)

US4260630A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-08-14 1988-02-13 1988-08-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-08-14 1992-02-13 1992-08-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-08-14 1996-02-13 1996-08-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag